Celltaxis
PrivateLast Round
Series A
Jun 4, 2026
Total Funding Raised
$46M
Company Overview
Celltaxis operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Series A round in June 2026.
Celltaxis is a clinical-stage biotechnology company developing pharmaceutical therapies targeting lymphatic dysfunction, including lymphedema and lipedema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celltaxis Comparables
Compare Celltaxis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 77% | |
| Herantis Pharma Oyj | 70% | |
| PureTech Health | 68% |
For institutional investors. Book with your work email.
Celltaxis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 4, 2026 | ||||
| Seed | Mar 31, 2020 |
For institutional investors. Book with your work email.
Celltaxis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Masters Capital Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2020
Seed round led by Masters Capital Management.
For institutional investors. Book with your work email.
Celltaxis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celltaxis's valuation, stock price, and market status.
Is Celltaxis a public or private company?
Celltaxis is a private company.
What is the current stock price of Celltaxis?
Celltaxis is a private company, so its shares have no public market price. Caplight tracks Celltaxis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celltaxis worth (valuation)?
Valuation information for Celltaxis is not publicly available.
Can I buy Celltaxis stock?
Celltaxis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celltaxis's last funding round?
Celltaxis's most recent funding round was Series A on June 4, 2026.
Who are the main investors in Celltaxis?
Key investors in Celltaxis include Masters Capital Management.
Will Celltaxis IPO soon?
No public IPO plans have been announced for Celltaxis.
How can I track Celltaxis secondary market activity?
Caplight tracks bids, offers, and trades in Celltaxis's shares on secondary markets.